Skip to main content
Clinical Trials/NCT02664272
NCT02664272
Completed
N/A

Intraoperative Case Series Study: Trial Rasp Position Versus SL-PLUS™ MIA Ti/HA Femoral Hip Stem Position

Smith & Nephew Orthopaedics AG3 sites in 2 countries40 target enrollmentApril 6, 2016
ConditionsOsteoarthritis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Smith & Nephew Orthopaedics AG
Enrollment
40
Locations
3
Primary Endpoint
Mean Difference D Between the Position of the Last Trial Rasp and the Final Implant Position of the SL-PLUS™ MIA Ti/HA Femoral Hip Stem as Measured by an Intraoperative Fluoroscopic Measurement
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A prospective, multicenter, observational study using the SL-PLUS™ MIA Ti/HA femoral hip stem with the appropriate set of instruments.

Detailed Description

The study objective was to evaluate if there was a difference between the femoral position of the last trial rasp and the final implant position of the SL-PLUS™ MIA Ti/HA femoral hip stem. The femoral position of rasp or stem was considered as the height of the implant / rasp in cranio-caudal direction.

Registry
clinicaltrials.gov
Start Date
April 6, 2016
End Date
June 7, 2017
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Smith & Nephew Orthopaedics AG
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • requires primary THA with the SL-PLUS™ MIA Ti/HA femoral hip stem
  • is at least 21 years of age at the time of surgery
  • is skeletally mature in the PI's judgment
  • has consented to participate in the study by signing the EC approved ICF

Exclusion Criteria

  • requires the use of a ceramic-on-ceramic bearing
  • has infections, acute or chronic, local or systemic
  • has severe muscle, nerve or vascular diseases that endanger the respective limb
  • has lack of bone substance or defective bone quality that jeopardizes the stable seating of the prosthesis
  • has any concomitant disease that may jeopardize implant function
  • has a known allergy to study device or one or more of its components
  • requires a revision surgery and has extensive bone defects
  • has diagnosis of an immunosuppressive disorder
  • is pregnant

Outcomes

Primary Outcomes

Mean Difference D Between the Position of the Last Trial Rasp and the Final Implant Position of the SL-PLUS™ MIA Ti/HA Femoral Hip Stem as Measured by an Intraoperative Fluoroscopic Measurement

Time Frame: Intraoperative examination only

Difference D was measured using standardized fluoroscopic images taken during surgery. Investigators also reported any stem position corrections made as well as type of rasping instrument used. The difference D is given in millimeters (mm) and is defined as D = x1 - x2 with x1 being the distance between the shoulder of the trial rasp and the tip of the greater trochanter and x2 being the distance between the shoulder of the implant and the tip of the greater trochanter.

Secondary Outcomes

  • Number of Hips With Intraoperative Complications(Intraoperative examination only)
  • Number of Hips With Leg Length Discrepancy(Preoperative, directly postoperative (approximately 3 months))

Study Sites (3)

Loading locations...

Similar Trials